I'm almost a Muggle

Chapter 1130 This question is beyond the scope

Will Mr. Lin support himself?

That's a must!

Didn’t you see that Mr. Lin is becoming more and more satisfied with him?

What does this mean?

It means that your efforts have already achieved results.

And I also have a killer weapon.

Chen Yinhui followed Lin Dong and said goodbye to the staff in the live broadcast room and went to Lin Dong's office.

Lin Dong was also particularly satisfied with Chen Yinhui.

So I didn't refuse to have a good chat with him.

This is a good employee who can contribute to his huge losses and needs to add heavier burdens.

"Mr. Chen, thank you for your hard work recently."

The juicer brought a pot of tea, and Lin Dong personally poured it on Chen Yinhui.

"It's all right if you don't work hard or not." But I kept feeling happy in my heart if I didn't work hard.

The boss rarely brings tea and water to others.

There are not many people in the company who have such treatment.

"I've been doing well recently. I've been watching the live broadcast and it's almost a monopoly." Lin Dong said.

Chen Yinhui's heart suddenly stumbled.

This is not a word of praise.

If it were a certain goose, it said that a certain goose's scarf had already come back to life, killed the new wolf's Weibo, and there was also a hot search for meow. It was estimated that Bonima would dance for two hours.

Or Ali, it said that Taobao and Zhifubao have all their competitors.

Jackma will definitely be even more Versailles. Next time I guess I won’t say I don’t like money, but instead say I don’t like breathing air.

"Mr. Lin, in fact, Miaoya is far from monopolizing the entire live broadcast industry. The development of the live broadcast industry has entered a new field. It is no longer just live broadcasts. The live broadcast on Taobao is also very popular..."

"Taobao actually became an anchor..." Lin Dong was surprised.

He thought that only a certain goose was unwilling to give up and output it on short videos and live broadcasts.

Without genes, no matter how much output it is, you can't give birth to a baby.

Unexpectedly, Taobao started.

"Yes, Mr. Lin." Chen Yinhui was not fooling Lin Dong, but he did not explain the real situation in depth.

Live streaming of Taobao, Dong, and Pinxixi, such as live streaming of goods, are not considered real live streaming at all.

The live broadcast room is popular for millions.

In fact, besides robots, the rest are passers-by who are coming and leaving in a hurry.

"It's good if there is no monopoly." Lin Dong expressed satisfaction.

"Actually, there are many live broadcast websites outside that are very comfortable, such as those who look at legs, football, and even those who are too over-the-top." Chen Yinhui added consciously.

"Beasts, we must not do it!" Lin Dong expressed his indignation.

"Mr. Lin, don't worry, I am a principled person." Chen Yinhui patted his chest and promised.

In this case, Lin Dong would be relieved.

Everyone watches live broadcasts and will definitely like to watch legs and football. As long as Meowa sticks to this bottom line and does not relax, it will be impossible to form a monopoly.

"There is also a medical business department. I have invested in a movie called "The God of Medicine" before..." Lin Dong stood up, flipped through his bookcase, and quickly brought a file bag.

"Is this?" Chen Yinhui was confused.

"This is the script of the God of Medicine and some information. The movie will probably take July and August. You can take a look at this first." Lin Dong said.

"Do you need me to do anything?" Chen Yinhui was still confused.

This movie seems to have started to be promoted, but Qin Beier's affairs at that time had nothing to do with him.

"Forget it, let me tell you a brief story. This movie tells a heavy story, or it is not a story.

The protagonist Cheng Yong is the owner of a health care product store. His life is not satisfactory. There is an old father who is sick in bed and needs someone to take care of him, and a wife who wants to take his son out of the pot. The burden of life is too heavy to breathe. In order to make money, Cheng Yong had to take the risk to agree to the leukemia patient Lu Shouyi to start the business of smuggling "extradition Glenin"..."

Lin Dong began to tell Chen Yinhui about this movie.

This movie is a classic case of his investment failure, but Lin Dong does not regret bringing this movie to the audience.

"For leukemia, it should be Gleevec. I know this medicine. It is the most effective drug to treat leukemia so far, but it seems to be quite expensive." Chen Yinhui immediately responded.

"How did you know?" Lin Dong was speechless. You said that you are a gangster who specializes in aquaculture. Where did you get the knowledge?

"Hehe, Mr. Lin, you asked me to be in charge of the medical department. I must work hard to do my homework." Chen Yinhui thought the boss was admiring him.

Lin Dong didn't want to worry about this for the time being and said, "This kind of medicine needs 20,000 yuan per bottle for us. Do you know how much it costs to extradite a bottle?"

"I haven't studied the extradition yet."

Boss, don’t play like this. Even if you hope that I will do my homework after taking over the medical department, and try to make this department bigger and stronger as soon as possible.

There is no need to ask me about extradition.

This question is beyond the scope.

"Two hundred yuan!" Lin Dong said with emotion.

He is now considered a rich man. Whether it is a cat factory or his personal wealth, his wealth is definitely more than 98%.

But he would still be inexplicably sad and angry at this situation.

"I actually know this a little bit," Chen Yinhui tried to look at the problem from a more objective perspective:

"Because Zheng Ce is very relaxed in the extradition patent, as long as the ingredients of the drug are analyzed and slightly changed without affecting the efficacy of the drug, it will have its own patent. Only then can the extradition pharmaceutical factory dare to produce in large quantities, but it won't work on our side. Our patent is very strict, so we can only buy genuine medicines."

"The difference is too big."

"This is because of the huge investment in Novartis Pharmaceuticals, which has a total investment of 80 billion Chinese currency..." Everyone has a position. From Chen Yinhui's standpoint, he prefers Novartis Pharmaceuticals.

Around 1996, Novartis independently developed the targeted therapeutic drug for chronic myeloid leukemia Gleevec.

The total investment is as high as 80 billion.

What is the concept of 80 billion in that era?

It can really be said that if you fail, you will go bankrupt.

The drug was launched in 2001. As a first-line drug for chronic myeloid leukemia in Philadelphia, Gleevec has an effective efficiency of up to 95%.

It can really be said to save countless people.

From 1970 to 2011, Novartis and its predecessors won the Nobel Prize in the Drug Industry 29 times, of which Gleevec took 10 times.

In addition to the huge investment in R&D, companies need to make profits.

There is also something called the "patent cliff" in the pharmaceutical industry, which is also working.

The so-called patent cliff refers to the phenomenon that the performance of original pharmaceutical factories that rely on patent protection to obtain sales and profits after the expired drug patent protection expires.

When the patent expires, others can copy it.

Some common sayings are that the original drug has a patent protection period of 20 years, but these 20 years are calculated from registration. Judging from the actual situation of Gleevec, the real peak sales of this drug is actually only a little over 10 years.

After Gleevec went public, sales have been rising year by year, exceeding US$1 billion in three years. Since then, it has continued to grow and reached its peak of US$4.6 billion in 2011.

After maintaining its peak of US$4.6 billion for four years, Gleevec's patent protection expired in 2015. Since 2016, Gleevec's sales have declined sharply.

This is why they sell so expensively.

It's not that the cost is high.

The cost is actually not high at all. If the cost is high, extradition will not be sold for 200 bottles.

From 2014 to 2017, Novartis' total R&D expenditure was approximately US$36.032 billion, equivalent to approximately RMB240.95 billion in China Coin.

With such a high R&D investment, where does the money come from?

Chen Yinhui did his homework and explained the logic of the medical industry to his boss.

Boss, your butt is crooked.

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like